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The aim of this study was to assesses the relation between Serum Magnesium Level and Severity and Frequency 
of Migraine Headache Attacks. The study was performed on 100 patients those were divided randomly into two 
groups (Migraine patients and healthy patients each with 50 cases). For the first group (migraine patients) in 
addition to the usual migraine medication, magnesium oxide pills were prescribed and for healthy patients 
placebo was administered. Changes in the serum magnesium levels, severity and frequency of migraine 
headache attacks, one and three months after the start of the study were evaluated and collected data analyzed by 
statistical methods in SPSS.16. In migraine patients, 26% and in healthy patients, 30% were male and rests of 
them were female. All patients were aged 18-65 years. At one month and three months after intervention, the 
mean serum magnesium levels and headache severity was similar between two groups. One month later, 
reducing the number of headache attacks in the migraine patient was similar to the healthy patients  but three 
months later, there was significant difference between two groups. (P= 0.004). Results showed that 
administration of magnesium can reduce the number of migraine attacks and can be more effective in preventing 
of disease. 
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INTRODUCTION 
 
Headache is a common disease and occurs in allages. 
Chronic headaches are usually benign, although each acute attack 
may be highly debilitating. Of evaluated headaches in the 
emergency and clinic, about 38% and 44% are migraine 
headache, respectively.  The prevalence of migraine headache in 
women was 3-18% and in men was 4-6 % (Aminoff et al., 2009; 
Talebi et al., 2011). Migraine appears often as one-sided 
pulsating chronic headache and usually accompanied by nausea, 
vomiting, photophobia, and a feeling of fatigue. Sometimes 
migraine headache is severe and disrupts the patient's daily 
activities. Treatment of  migraine often requires long-term use of  
    
 
* Corresponding Author 
Email: g.fattahzadeh2015@gmail.com 
 
 
 
 
 
 
 
 
 
 
 
 
drug, so majority of patients, as well as pregnant  women and 
people with heart disease shun long-term and regular use of 
medications. In more than20% of patients in addition to headaches, 
symptoms of mood, appetite and cognitive is created. Most of 
patients are with a family history of migraine (Aminoff et al., 
2009). Some probable mechanisms have been described to the 
relationship between magnesium (Mg) level and migraine 
headache attacks (Samaie et al., 2012). Previous studies on 
migraine have shown various results in relation between level of 
magnesium and incidence of migraine attacks (Welch and Tayi, 
2006; Masoud, 2003). Due to the high prevalence of migraine, 
complications and effective symptoms on patient quality of life, 
limitations on the use of appropriate treatment and the need to 
prevent attacks of the disease, doing research on this disease is 
essential. This study aimed to determine the effect of magnesium 
level on severity and frequency of migraine attacks in patients. 
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METHODS 
 
This clinical trial study has been done on 100 referred 
patients to hospital with headache which have inclusion criteria 
and completed the consent form before study. All patients divided 
randomly in two groups each with 50 patients and the Valproate 
sodium, Propranolol, Ibuprofen or Gelofen tablets prescribed for 
all patients. In addition to routinely drugs, patients in case group 
received Magnesium oxide tablets (250 mg/ 12 h) by orally and 
patients in control group received placebo. All patients were 
advised to take their medication regularly and follow migraine 
elimination diet.  
Assessment of the severity and number of migraine 
attacks was measured for all patients in three visits (on admission, 
one month later and three months later) by clinical examination in 
the neurology clinic by neurologist. Also the level of magnesium 
measured for all patients in three times. For the measurement of 
magnesium in laboratory, 5 ml of blood sample was taken from 
each patient and put in the centrifuge at 1500 rpm for 15 minutes. 
After separation serum, magnesium concentration was measured 
by colorimetric by auto analyzer.Collected data analyzed by 
statistical methods in SPSS.16. The p<0.05 was considered as 
significant. The study design was approved by Ardabil University 
of Medical Sciences ethical committee. 
 
RESULTS  
 
Of all patients 32% were male and rest of them was 
female. The age range of patients was 18-65 and most of them 
were in age groups 30-44 with 56%.Maximum duration of illness 
in 33% of patients was 1 to 4 years. 53% of patients have Migraine 
with aura and 47% without aura. In first referral in case group 25 
(50%) have 7-10attacks in month and in control group 25(50%) 4-
6 attacks in month and the difference between two group was 
significant.  
 
Table 1: Number of attacks by two groups in all visits. 
Group Visit Number attacks N(%) p-value 
B
as
el
in
e
 Case 
1-3 9(18) 
0.045 
4-6 16(32) 
7-10 25(50) 
Control 
1-3 12(24) 
4-6 25(50) 
7-10 13(26) 
O
n
e 
m
o
n
th
 
la
te
r 
Case 
26(52) 1-3 
0.89 
21(42) 4-6 
3(6) 7-10 
Control 
24(48) 1-3 
23(46) 4-6 
3(6) 7-10 
T
h
re
e 
m
o
n
th
 
la
te
r 
Case 
1-3 37(74) 
0.004 
4-6 12(24) 
7-10 1(2) 
Control 
1-3 22(44) 
4-6 28(56) 
7-10 2(4) 
 
The number of headache attacks in one and three month 
after magnesium administration evaluated and compared between 
two groups. Results showed that there wasn’t significant 
difference between two groups after one month but third visit 
(after three month) the number of attacks in case group was lowers 
than control group (p=0.004) (Table 1). 
Changing the severity of headache attacks is one of the 
criteria which evaluated in all three time visits. In first visit in case 
and control groups 39 (78%) and 32 (64%) have severe headache 
which was statistically significant between two groups.  The rate 
of severity headache decreased between two groups after follow-
up time but there weren’t statistically significant differences 
between two groups in second and third visits (Table 2). 
 
Table 2:  Severity of attacks by two groups in all visits. 
Group Visit Number attacks N(%) p-value 
B
as
el
in
e
 Case 
Mild 0 
0.1 
Moderate 11(22) 
Severe 39(78) 
Control 
Mild 0 
Moderate 18(36) 
Severe 32(64) 
O
n
e 
m
o
n
th
 
la
te
r 
Case 
Mild 7(14) 
0.15 
Moderate 30(60) 
Severe 13(26) 
Control 
Mild 6(12) 
Moderate 24(18) 
Severe 20(40) 
T
h
re
e 
m
o
n
th
 
la
te
r 
Case 
Mild 19(38) 
0.17 
Moderate 22(44) 
Severe 9(18) 
Control 
Mild 12(24) 
Moderate 27(54) 
Severe 11(22) 
 
The level of magnesium in first visit was similar between 
two groups each with 1.9 mg/dl. All of patients observed the 
national migraine diet and proper use of common migraine drugs 
and magnesium oxide in follow-up time. Also, all patients checked 
in terms of specific diseases which in case group 8(16%) and 
control group 4(8%) have cold. The mean of magnesium after 
three month increase in case group to 2.208 and in control group to 
1.922 from baseline, but this rising no statistically significant 
between and whiten two groups. (Figure 1) 
 
 
Fig. 1: Mean of serum magnesium in patients of two groups during follow-up 
time. 
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DISCUSSION  
 
In this study rate of headache attacks three month after 
drug administration in case group significantly decreased compare 
to control group. (p=0.004). In a study (Welch and Tayi, 2006) 
found that decreasing magnesium cause to decreasing 
Physiological threshold and increasing number of headache attacks 
and increasing magnesium cause to decreasing attacks of migraine 
headache. Masoud et al in a study showed that incidence number 
of attacks hasn’t significant relation with mean of serum 
magnesium (Masoud, 2003). In a study done by Roodbari and 
Abrishamizadeh (2008) results showed that increasing serum 
magnesium in patients deal to decreasing the number of headache 
attacks in patients. In another study the role of low level serum 
magnesium in incidence of migraine attacks and conversely was 
proven (Qujeq et al., 2009). 
In this study there weren’t significant differences in 
serum magnesium level between two groups in baseline and 
during follow-up time. Some of studies confirmed this result such 
as Mauskop (2008) and Nouri (2007) and some studies not similar 
to this study (Aloidisil, 2007; Kelon, 2010). Samaie et al (2012) in 
a study showed that Serum Mg level is on average significantly 
reduced in patients with migraine compared to the healthy group. 
Also showed that the serumtotal Mg levels in migraineurs 
remained constant within and between migraine headache attacks. 
Roodbari and et al in a study was proved that increasing serum 
magnesium levels can help sedation the severity of migraine in 
20% of patients which was consistent with the results of our study 
(Roodbari and Abrishamizadeh, 2008). 
 
CONCLUSION 
 
Results of this study showed that administration of 
magnesium pill in patients with migraine headache couldn’t 
significantly reduce the severity of headache but was able to 
reduce the number of migraines and effective to prevent it.  
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